Mirati Therapeutics Inc (NASDAQ:MRTX)

132.48
Delayed Data
As of Dec 03
 -4.58 / -3.34%
Today’s Change
130.97
Today|||52-Week Range
249.42
-39.68%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Mirati Therapeutics Inc have a median target of 212.00, with a high estimate of 300.00 and a low estimate of 171.00. The median estimate represents a +60.02% increase from the last price of 132.48.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Mirati Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.99
Sales
$1.3M
Reporting Date
Mar 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -92.86%
 
 
 
 
 
 
Growthannually -32.79%
 
 
 
 
 
 

Sales

Growthquarterly -98.26%
 
 
 
 
 
 
Growthannually 409.15%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.